Correlation of nitrites in breath condensates and lung function in asthmatic children

Pediatric Allergy and Immunology

Volumn 15, Issue 1, 2004, Pages 20-25

  Straub, Daniel A ^a,e   Ehmann, Rainer ^a,c   Hall, Graham L ^a,b   Mœller, Alexander ^a   Hamacher, Jürg ^d   Frey, Urs ^b   Sennhauser, Felix H ^a   Wildhaber, Johannes H ^a  

^a University Hospital   (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c Allergy Clinic   (Switzerland)

^d UNIVERSITY OF KONSTANZ   (Germany)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Airway inflammation; Bronchial hyperreactivity; Childhood asthma; Forced expiratory volume; Nitrites

Indexed keywords

ANTIINFLAMMATORY AGENT; HOUSE DUST ALLERGEN; NITRITE;

ADOLESCENT; ALTITUDE ACCLIMATIZATION; ARTICLE; ASTHMA; BREATH ANALYSIS; BREATH CONDENSATE; BRONCHUS HYPERREACTIVITY; CHILD; CLIMATOTHERAPY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE ACTIVITY; EXHALED BREATH CONDENSATE; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HIGH ALTITUDE CLIMATE THERAPY; HUMAN; INFLAMMATION; INHALATION TEST; LUNG FUNCTION; MALE; PRICK TEST; PRIORITY JOURNAL; SPIROMETRY;

ADOLESCENT; ALTITUDE; ASTHMA; BREATH TESTS; CHILD; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; NITRITES; PILOT PROJECTS; RESPIRATORY FUNCTION TESTS;

EID: 1542328178     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0905-6157.2003.00099.x     Document Type: Article

References (33)

1. CAI Y, CARTY K, HENRY RL, GIBSON PG. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children. Eur Respir J 1998: 11: 848-53.
2. GIBSON PG, HENRY RL, THOMAS P. Non-invasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000: 16: 1008-15.
3. WENNERGREN G. Inflammatory mediators in blood and urine. Pediatr Resp Rev 2000: 1: 259-65.
4. KRISTJANSSON S, STRANNEGARD IL, STRANNEGARD O, PETERSON C, ENANDER I, WENNERGREN G. Urinary eosinophil protein X in children with atopic asthma: a useful marker of antiinflammatory treatment. J Allergy Clin Immunol 1996: 97: 1179-87.
5. WILSON NM, JAMES A, UASUF C, et al. Asthma severity and inflammation markers in children. Pediatr Allergy Immunol 2001: 12: 125-32.
6. LONNKVIST K, HELLMAN C, LUNDAHL J, HALLDEN G, HEDLIN G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J Allergy Clin Immunol 2001: 107: 812-7.
7. BARNES P, ALVING K, KHARITONOV S, CHEESEMAN K. Exhaled markers in airway disease. Eur Respir Rev 1999: 9: 207-50.
8. BYRNES CA, DINAREVIC S, SHINEBOURNE EA, BARNES PJ, BUSH A. Exhaled nitric oxide measurements in normal and asthmatic children. Pediatr Pulmonol 1997: 24: 312-8.
9. BARALDI E, AZZOLIN NM, ZANCONATO S, DARIO C, ZACCHELLO F. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997: 131: 381-5.
10. BISGAARD H, LOLAND L, OJ JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 1999: 160: 1227-31.
11. GARRA S, GAGLIARDI L, ZANCONATO S, et al. Budesoride but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. Respir Med 2001: 95: 734-9.
12. DOHLMAN AW, BLACK HR, ROYALL JA. Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993: 148 (4 Pt 1): 955-60.
13. JOBSIS Q, RAATGEEP HC, HERMANS PW, DE JONGSTE JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997: 10: 519-21.
14. CORRADI M, MONTUSCHI P, DONNELLY LE, PESCI A, KHARITONOV SA, BARNES PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001: 163: 854-8.
15. FORMANEK W, INCI D, LAUENER RP, WILDHABER JH, FREY U, HALL GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J 2002: 19: 487-91.
16. PREHN A, SEGER RA, TORRESANI T, MOLINARI L, SENNHAUSER FH. Evaluation of a clinical algorithm involving serum eosinophil cationic protein for guiding the anti-inflammatory treatment of bronchial asthma in childhood. Pediatr Allergy Immunol 2000: 11: 87-94.
17. ZAPLETAL A. Lung function in children and adolescents. In: HERZOG H, ed. Progress in Respiration Research. Karger: Basel, 1987: 173-96.
18. Skin tests used in type I allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989: 44 (Suppl 10): 1-59.
19. GUEVARA I, IWANEJKO J, DEMBINSKA-KIEC A, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta 1998: 274: 177-88.
20. CRAPO RO, CASABURI R, COATES AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000: 161: 309-29.
21. GIBSON PG, WLODARCZYK JW, HENSLEY MJ, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med 1998: 158: 36-41.
22. SIMON HU, GROTZER M, NIKOLAIZIK WH, BLASER K, SCHONI MH. High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma. Pediatr Pulmonol 1994: 17: 304-11.
23. JATAKANON A, LIM S, KHARITONOV SA, CHUNG KF, BARNES PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998: 53: 91-5.
24. WARKE TJ, FITCH PS, BROWN V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax 2002: 57: 383-87.
25. GRIESE M, KOCH M, LATZIN P, BECK J. Asthma severity, recommended changes of inhaled therapy and exhaled nitric oxide in children: a prospective, blinded trial. Eur J Med Res 2000: 5: 334-40.
26. BECK-RIPP J, GRIESE M, ARENZ S, KORING C, PASQUALONI B, BUflER P. Changes of exhaled nitric oxide during steroid treatment of childhood asthma. Eur Respir J 2002: 19: 1015-9.
27. MONTUSCHI P, BARNES P. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002: 23: 232-37.
28. BJERMER L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001: 95: 703-19.
29. LIPWORTH BJ, CLARK DJ. Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax 1997: 52: 1036-9.
30. BOUSQUET J, JEFFERY PK, BUSSE WW, JOHNSON M, VIGNOLA AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000: 161: 1720-45.
31. JEFFERY P. Inflammation and remodeling in the adult and child with asthma. Pediatr Pulmonol 2001: 21 (Suppl.): 3-16.
32. VAN VELZEN E, VAN DEN BOS JW, BENCKHUIJSEN JA, VAN ESSEL T, DE BRUIJN R, AALBERS R. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996: 51: 582-4.
33. BONER AL, PERONE DG, PIACENTINI GL, VENGE P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 1993: 23: 1021-6.